Form 4 for SRTA Strata Critical Medical, Inc.

Accepted 2026-08-03 16:06:02 ET · period of report 2026-07-30 · accession 0001628280-26-051811 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2026-08-03 16:06	2026-07-30	SRTA	Tomkiel Melissa M.	GC, Co-CEO, Dir	A - Grant	$0.00	+415.9K	2.31M	+22%	$0
	2026-08-03 16:06	2026-07-31	SRTA	Tomkiel Melissa M.	GC, Co-CEO, Dir	F - Tax	$5.09	-212.3K	2.10M	-9%	-$1.08M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A common stock, $0.0001 par value per share	2026-07-30	A	A	208,929	$0.00	2,101,703	D	—	—	(F1) Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 8, 2024.
2	Common	Class A common stock, $0.0001 par value per share	2026-07-30	A	A	206,953	$0.00	2,308,656	D	—	—	(F2) Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 20, 2025.
3	Common	Class A common stock, $0.0001 par value per share	2026-07-31	F	D	212,309	$5.09	2,096,347	D	—	—	(F3) Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs.